期刊文献+

高脂培养抑制LPS诱导的HSC-T6细胞活化

The Fat Culture Inhabited LPS-Induced Activation of HSCs-T6 Cells
原文传递
导出
摘要 目的:鉴定高脂培养对肝星形细胞活化的影响。方法:培养HSC-T6细胞系,加入含有游离脂肪酸的高脂培养基处理,利用LPS处理活化,通过检测α-SMA的表达分析星形细胞的活化程度,通过Q-PCR分析HSCs细胞胶原的表达,通过Q-PCR实验分析LPS相关通路靶基因表达情况情况。结果:高脂培养能够抑制LPS诱导的HSC-T6细胞增殖,降低HSC-T6细胞α-SMA和胶原I和TIMP-1表达的水平,Q-PCR的分析表明,高脂培养能够抑制HSCs活化后的NF-κB通路下游靶基因MCP-1和IL-6的表达。结论:在体外培养实验中,高脂培养能够抑制LPS诱导的HSC-T6细胞活化。 Objective: To investigate the effect of high-fat medium on the activition of hepatic stellate cells. Methods: HSC-T6 cell line was cultured, and treated with high-fat medium which containing flee fatty acid, activated with LPS. The degree of activation was analyzed by detecting α-SMA expression. The expression of collagen-I and TIMP-1 was analyzed by Q-PCR, and the activation of transcription factor which related to LPS pathway was analyzed by Q-PCR assay. Results: High-fat medium was able to inhibit the activation of HSC-T6 cells which induced by LPS, reduced the expression of collagen level in the HSC-T6 cells. Q-PCR analysis showed that the high-fat medium inhibited the expression of MCP-1 and IL-6 which were the target genes of NF-KB in activated HSCs. Conclusion: In vitro culture experiments, high-fat medium can inhibit the activation of HSC-T6 cells which induced by LPS.
出处 《现代生物医学进展》 CAS 2014年第8期1420-1422,共3页 Progress in Modern Biomedicine
基金 国家自然科学基金项目(31000405) 国家高技术研究发展计划(2012AA020201) 重大科学仪器研究专项(2013YQ140405) 国家"艾滋病和病毒性肝炎等重大传染病防治"科技重大专项(2013ZX10002009-001)
关键词 游离脂肪酸 肝星形细胞 LPS 肝纤维化 Free fatty acids HSC-T6 LPS Liver fibrosis
  • 相关文献

参考文献20

  • 1Wells RG. Mechanisms of liver fibrosis: new insights into an old problem[J]. Elsevier Journal, 2006, 3(4): 489-495.
  • 2Giuseppe P. Pathogenesis of liver fibrosis: role of oxidative stress[J]. Molecular Aspects of Medicine, 2000, 21 (3): 49-98.
  • 3Friedman SL, Bansal MB. Reversal of hepatic fibrosis: Fact or fantasy [J].Hepatology, 2006, 43(2-1): S82-S88.
  • 4Benyon RC, Iredale JP. Is liver fibrosis reversible[J].Gut, 2000, 46(4): 443-446.
  • 5Friedman SL. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury [J]. J Biol Chem, 2000, 275 (4): 2247-2250.
  • 6Bataller R, Brenner DA. Liver fibrosis [J]. J Clin Invest, 2005, 115(4): 209 -218.
  • 7Kisseleva T, Cong M, Paik YH, et al. Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis [J]. Proceedings of the National Academy of Sciences of the United States of America, 2012, 109(24): 9448-53.
  • 8Bemd S, Katharina B, Marina F, et al. A TLR4/MD2 fusion protein inhibits LPS-induced pro-inflammatory signaling in hepatic stellate cells [J]. Biochemical and Biophysical Research Communication, 2008, 375(2): 210-214.
  • 9Matthew LC, Rahman TM, Sanjeev K. Proteomic approaches in the search for biomarkers of liver fibrosis [J]. Trends in Molecular Medicine, 2010, 16(4): 171-183.
  • 10Friedman SL. Mechanisms of disease: mechanisms of hepatic fibrosis and therapeutic implications[J]. Nat Clin Pract Gastroenterol Hepatol 2004, 1(2): 98-105.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部